Business Description
Formosa Pharmaceuticals Inc
ISIN : TW0006838006
Compare
Compare
Traded in other countries / regions
6838.Taiwan IPO Date
2021-10-07Description
Formosa Pharmaceuticals Inc is a late-preclinical and early-clinical stage biopharmaceutical company with focus in the indications of ophthalmology, oncology, and anti-infectives.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 35.85 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.21 | |||||
| Beneish M-Score | -1.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 6.5 | |||||
| 3-Year EPS without NRI Growth Rate | 4.8 | |||||
| 3-Year FCF Growth Rate | 13.5 | |||||
| 3-Year Book Growth Rate | 46.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.99 | |||||
| 9-Day RSI | 43.35 | |||||
| 14-Day RSI | 46.17 | |||||
| 6-1 Month Momentum % | -14.17 | |||||
| 12-1 Month Momentum % | -10.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.67 | |||||
| Quick Ratio | 6.67 | |||||
| Cash Ratio | 6.22 | |||||
| Days Sales Outstanding | 59.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.4 | |||||
| Shareholder Yield % | -0.16 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 86.96 | |||||
| Operating Margin % | -172.64 | |||||
| Net Margin % | -226.46 | |||||
| FCF Margin % | -78.5 | |||||
| ROE % | -26.18 | |||||
| ROA % | -17.67 | |||||
| ROIC % | -50.33 | |||||
| 3-Year ROIIC % | -49.61 | |||||
| ROC (Joel Greenblatt) % | -779.83 | |||||
| ROCE % | -17.42 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 43.69 | |||||
| PB Ratio | 5.78 | |||||
| Price-to-Tangible-Book | 8.97 | |||||
| EV-to-EBIT | -21.41 | |||||
| EV-to-EBITDA | -25.49 | |||||
| EV-to-Revenue | 41.72 | |||||
| EV-to-FCF | -54.29 | |||||
| Price-to-Net-Current-Asset-Value | 9.82 | |||||
| Price-to-Net-Cash | 11.24 | |||||
| Earnings Yield (Greenblatt) % | -4.67 | |||||
| FCF Yield % | -1.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Formosa Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 133.701 | ||
| EPS (TTM) (NT$) | -2.505 | ||
| Beta | 1.18 | ||
| Volatility % | 41.59 | ||
| 14-Day RSI | 46.17 | ||
| 14-Day ATR (NT$) | 1.475677 | ||
| 20-Day SMA (NT$) | 44.3025 | ||
| 12-1 Month Momentum % | -10.12 | ||
| 52-Week Range (NT$) | 36.9 - 66.9 | ||
| Shares Outstanding (Mil) | 150.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Formosa Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Formosa Pharmaceuticals Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Formosa Pharmaceuticals Inc Frequently Asked Questions
What is Formosa Pharmaceuticals Inc(TPE:6838)'s stock price today?
The current price of TPE:6838 is NT$43.60. The 52 week high of TPE:6838 is NT$66.90 and 52 week low is NT$36.90.
When is next earnings date of Formosa Pharmaceuticals Inc(TPE:6838)?
The next earnings date of Formosa Pharmaceuticals Inc(TPE:6838) is .
Does Formosa Pharmaceuticals Inc(TPE:6838) pay dividends? If so, how much?
Formosa Pharmaceuticals Inc(TPE:6838) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers